oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

Atofab

Out-of-specification (OOS) results were found in reference samples for the atomoxetine content parameter, which may affect the quality and effectiveness of the medicine. Potential effects: lack or reduced treatment efficacy, possible worsening of disease symptom control.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Atofab
Risk Level
Medium
Manufacturer
G.L. Pharma GmbH z siedzibą w Austrii
Batch Number
E01580
EAN Code
09008732012224
Recall Date
09.08.2024
View official statement

Important Information

What You Should Know

Recommendations

Do not use Atofab from batches E01580 and FQ6874, check the batch number on the pack; if you have these batches, consult a pharmacist or doctor to obtain an appropriate replacement or further advice.

Actions Taken

Suspension throughout the country of the marketing of batches E01580 and FQ6874 of the medicinal product Atofab (Atomoxetine), hard capsules, 25 mg and 40 mg, and granting the decision immediate enfor...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: Out-of-specification (OOS) results were found in reference samples for the atomoxetine content parameter, which may affect the quality and effectiveness of the medicine. Potential effects: lack or reduced treatment efficacy, possible worsening of disease symptom control.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: E01580

Related

Other Recalled Products